SJ Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Not a good buy right now for an impatient investor. SJ is extended after an 8.45% regular-session pop and is trading close to the first key resistance (R1 ~1.501) while momentum is starting to cool (MACD histogram still positive but contracting). With no Intellectia buy signals today and price sitting near resistance rather than support, the risk/reward favors waiting for a pullback toward the pivot area (1.18–1.20) before considering an entry.
Trend/structure: Bullish trend setup with moving averages stacked positively (SMA_5 > SMA_20 > SMA_200), indicating an established uptrend. Momentum: MACD histogram is above zero (0.0443) but positively contracting, suggesting bullish momentum is slowing rather than accelerating. RSI: RSI_6 at ~71.14 is elevated (near overbought territory), implying price may be stretched in the short term. Levels: Pivot ~1.179 is the key near-term support reference; resistance levels are R1 ~1.501 and R2 ~1.701. With price at ~1.40, upside to R1 is limited versus downside back to pivot. Pattern-based bias: Similar-pattern stats suggest modest expected gains over week/month (1.91% / 2.28%), not a high-conviction near-term breakout signal.
Intellectia Proprietary Trading Signals
with slowing momentum (contracting MACD histogram).
Latest quarter: 2025/Q3. Revenue fell to 302,885,000 (-5.75% YoY), indicating top-line contraction. Profitability improved sharply: Net income rose to 6,749,000 (+775.36% YoY) and EPS increased to 0.16 (+700% YoY), suggesting a low prior-year base and/or cost/one-time effects supported earnings. However, gross margin dropped to 18.07 (-5.98% YoY), a negative trend that matters for the sustainability of profit gains.
No analyst rating / price target change data was provided, so there is no observable recent Wall Street upgrade/downgrade trend to validate the move. Pros view (inferred from available info): the AI streamer commercialization and global expansion narrative can support upside sentiment. Cons view: declining revenue and weaker gross margin raise questions about durable growth/quality of earnings, making the stock more headline- and execution-driven than fundamentally re-rated.
